Elevated IGF2BP3 levels were significantly associated with advanced tumor stages in gastric cancer and higher tumor grades in colorectal cancer, indicating its involvement in tumor progression and differentiation. This evidence concerns the gene IGF2BP3 and colorectal cancer.